Lestinora

Melatonin, the active ingredient in Lestinora, is a melatonin receptor agonist presented as an oral formulation for oral use. It helps manage insomnia, sleep onset difficulties and jet lag in adults.

GNH USA supplies Lestinora as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for healthcare providers across multiple regions. All batches are manufactured under GMP conditions and undergo full regulatory review before distribution. Customers benefit from competitive pricing and comprehensive technical support.

Lestinora (melatonin) acts on melatonin receptors to regulate the sleep‑wake cycle, addressing several sleep‑related conditions.

Insomnia: improves sleep initiation and maintenance in individuals with difficulty falling or staying asleep. Sleep onset difficulties: reduces the time required to fall asleep for people experiencing delayed sleep onset. Jet lag: helps realign circadian rhythms after rapid travel across time zones.

Melatonin is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Drowsiness or daytime sleepiness. - Headache. - Dizziness. - Nausea.

Serious or Rare Side Effects: - Allergic reaction such as rash, itching, swelling, or difficulty breathing. - Mood changes, including depression or agitation, especially with high doses.

When considering melatonin therapy, several precautionary measures should be observed.

Assess underlying conditions: evaluate for sleep disorders, depression, or seizure disorders before use. Review concomitant medications: check for interactions with anticoagulants, immunosuppressants, or CNS depressants. Adjust dosing in the elderly: start with the lowest effective dose due to increased sensitivity. Avoid use in children unless advised by a pediatric specialist. Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Melatonin may interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding risk. - Immunosuppressants (e.g., cyclosporine): may alter drug levels.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedation. - Antidiabetic agents: possible effect on glucose control. - Hormonal contraceptives: may reduce effectiveness.